Showing results (241-250 of 398) with videos related to
Sort By:
Pageof 40
The Journal of Antimicrobial Chemotherapy|June 16, 2025
Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023)Helio S Sader, John H Kimbrough, Marisa L Winkler, et al.Open Forum Infectious Diseases|April 14, 2025
Frequency, Antimicrobial Susceptibility, and Molecular Characterization of Carbapenem-Resistant Enterobacterales Stratified by United States Census Divisions: Results From the INFORM Program (2018-2022)Helio S Sader, John H Kimbrough, Timothy B Doyle, et al.American Journal of Obstetrics and Gynecology|February 1, 1991
Neonatal complications at term as related to the degree of umbilical artery acidemiaC L Winkler, J C Hauth, J M Tucker, et al.BMC Public Health|April 19, 2023
Involving supermarkets in health promotion interventions in the Danish Project SoL. A practice-oriented qualitative study on the engagement of supermarket staff and managersLise L Winkler, Ulla Toft, Charlotte Glümer, et al.BMC Public Health|June 15, 2014
Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approachPooja Bansil, Scott Wittet, Jeanette L Lim, et al.Journal of Global Antimicrobial Resistance|July 27, 2025
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus of diverse genetic typesMarisa L Winkler, John H Kimbrough, Helio S Sader, et al.Antibiotics (Basel, Switzerland)|June 25, 2025
Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019-2023)Helio S Sader, John H Kimbrough, Marisa L Winkler, et al.Mycoses|July 8, 2026
Reduced Activity of Triazole Antifungal Agents Against Aspergillus tubingensis From a Global Collection of Genomically-Characterized Aspergillus Section Nigri Clinical Isolates (2020-2023)John H Kimbrough, Marisa L Winkler, Maura H Karr, et al.Journal of the National Cancer Institute|June 21, 2001
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1F Jänicke, A Prechtl, C Thomssen, et al.International Journal of Oncology|May 11, 2011
Model system for isolation of competent ovarian-carcinoma cells from fresh tumor-tissue by a magnetic separation technique (macs)N Harbeck, S Schwarze, E Schuren, et al.Pageof 40